Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 8/20 | 0.40 |
| ▸ | PYGL | P06737 | 3/20 | 0.34 |
| ▸ | PYGM | P11217 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.32 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14977692 | 0.84 | PYGB (0.37) | PYGBPYGLPYGML3MBTL1 | |
| SCHEMBL2364472 | 0.74 | PYGB (0.42) | PYGBPYGLPYGML3MBTL1 | |
| SCHEMBL3655173 | 0.72 | PYGB (0.37) | PYGBPYGLPYGML3MBTL1SLC5A2 | |
| SCHEMBL8521615 | 0.71 | CDK1 (0.36) | PYGBPYGLPYGM | |
| SCHEMBL7855354 | 0.71 | PYGB (0.36) | PYGBPYGLPYGML3MBTL1 | |
| SCHEMBL17781741 | 0.68 | PYGB (0.43) | PYGBPYGLPYGMSLC5A2SLC5A1 | |
| SCHEMBL5062195 | 0.67 | PYGB (0.48) | PYGBPYGLPYGM | |
| SCHEMBL27453207 | 0.67 | PYGB (0.44) | PYGBPYGLPYGMSLC5A2SLC5A1 | |
| SCHEMBL28575710 | 0.67 | PYGB (0.48) | PYGBPYGLPYGM | |
| SCHEMBL23349270 | 0.67 | PYGB (0.39) | PYGBPYGLPYGML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 501 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2367852-B1 | COSMETIC COMPOSITION CONTAINING ACETYLATED OLIGOGLUCURONANS | SEDERMA SA (FR) | 2023-08-30 | — | — | EP | disclosed |
| EP-3515564-B1 | FOAM COMPOSITIONS, AEROSOL PRODUCTS, AND METHODS OF USING THE SAME TO IMPROVE SENSORY BENEFITS TO THE SKIN | PROCTER & GAMBLE (US) | 2023-05-10 | — | — | EP | disclosed |
| EP-3744729-B1 | PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMOPHARMACEUTICAL USES | SEDERMA SA (FR) | 2023-03-01 | — | — | EP | disclosed |
| US-11331305-B2 | Peptides for skin rejuvenation and methods of using the same | ANTEIS SA (CH) | 2022-05-17 | — | — | US | disclosed |
| EP-3515401-B1 | FOAM COMPOSITIONS, AEROSOL PRODUCTS, AND METHODS OF USING THE SAME | PROCTER & GAMBLE (US) | 2022-02-09 | — | — | EP | disclosed |
| US-20210338558-A1 | USE OF COLLAGEN BINDING DOMAINS TO DELIVER PRODUCTS TO SKIN | FABIUS BIOTECHNOLOGY (US) | 2021-11-04 | — | — | US | disclosed |
| CN-107405292-B | Foam compositions, aerosol products and methods of using the same for improving skin sensory benefits | 宝洁公司 | 2021-07-13 | — | — | CN | disclosed |
| EP-3515397-B1 | STABLE FOAM COMPOSITIONS AND METHODS OF USING THE SAME TO PROVIDE ENHANCED SENSORY AND VISUAL BENEFITS TO SKIN | PROCTER & GAMBLE (US) | 2021-06-23 | — | — | EP | disclosed |
| EP-3744729-A1 | COMPOUNDS, IN PARTICULAR PEPTIDES, COMPOSITIONS COMPRISING THEM AND COSMETIC AND DERMOPHARMACEUTICAL USES | SEDERMA (FR) | 2020-12-02 | — | — | EP | disclosed |
| US-10842728-B2 | Light-absorbing compositions and methods of use | ALLELE BIOTECHNOLOGY & PHARMACEUTICALS, INC. (US) | 2020-11-24 | — | — | US | disclosed |
| US-5635469-A | MANUAL LIQUID CLEANSER DISPENSER HAVING FOAM-PRODUCING NOZZLE; NON-AEROSOL | THE PROCTER & GAMBLE COMPANY (US) | 1997-06-03 | — | — | US | disclosed |
| WO-1997007782-A1 | HIGH LATHER STYLING SHAMPOOS | THE PROCTER & GAMBLE COMPANY (US) | 1997-03-06 | — | — | WO | disclosed |
| US-5607980-A | AMPHOTERIC, ANIONIC, CATIONIC SURFACTANTS AND WATER | THE PROCTER & GAMBLE COMPANY (US) | 1997-03-04 | — | — | US | disclosed |
| WO-1997003647-A1 | TOPICAL COMPOSITIONS HAVING IMPROVED SKIN FEEL | THE PROCTER & GAMBLE COMPANY (US) | 1997-02-06 | — | — | WO | disclosed |
| WO-1997003648-A1 | COMPOSITIONS FOR TOPICAL DELIVERY OF ACTIVE INGREDIENTS | THE PROCTER & GAMBLE COMPANY (US) | 1997-02-06 | — | — | WO | disclosed |
| US-5585104-A | OIL IN WATER EMULSION; CLEANING COMPOUND | THE PROCTER & GAMBLE COMPANY (US) | 1996-12-17 | — | — | US | disclosed |
| WO-1996032092-A2 | CLEANSING EMULSIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-10-17 | — | — | WO | disclosed |
| US-5534265-A | INSOLUBILE POLYMER PARTICLES, GELLING AGENT, SURFACTANT, EMOLIENT | THE PROCTER & GAMBLE COMPANY (US) | 1996-07-09 | — | — | US | disclosed |
| WO-1996006595-A1 | PERSONAL CLEANSING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-03-07 | — | — | WO | disclosed |
| WO-1996006596-A1 | THICKENED NONABRASIVE PERSONAL CLEANSING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1996-03-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11331305-B2 | Peptides for skin rejuvenation and methods of using the same | CUTA, PLOD3, MMP13 | PYGB 3866/4885PYGL 4422/4885PYGM 1049/4885 |
| US-20210338558-A1 | USE OF COLLAGEN BINDING DOMAINS TO DELIVER PRODUCTS TO SKIN | COL14A1, COL2A1, COL1A1 | PYGB 3307/4885PYGL 2928/4885PYGM 896/4885 |
| US-10842728-B2 | Light-absorbing compositions and methods of use | CYBA, BROX, S100A6 | PYGB 1359/4885PYGL 2083/4885PYGM 169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.